MedTrace Logo

Liver Cancer Registry Platform

NCT04510740 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2025-05-01

No results posted yet for this study

Summary

The purpose of the project is to set up a national, prospective, longitudinal, multicenter cohort study with associated satellites, a tumor registry platform, to document uniform data on characteristics, molecular diagnostics, treatment and course of disease, to collect patient-reported outcomes and to establish a decentralized biobank for patients with Hepatocellular Carcinoma (HCC) or Cholangiocarcinoma (CCC) in Germany.

Conditions

Interventions

OTHER

Physician's choice according to patient's needs.

Routine care as per site standard.

Sponsors & Collaborators

  • iOMEDICO AG

    lead INDUSTRY

Principal Investigators

  • Thomas Berg, Prof.Dr. · Leipzig

  • Peter R. Galle, Prof.Dr. · Mainz

  • Wolf P. Hofmann, Prof.Dr. · Berlin

  • Achim Kautz · Köln

  • Philippe Pereira, Prof.Dr. · Heilbronn

  • Karin Potthoff, Dr. · Freiburg im Breisgau

  • Jan Schröder, PD Dr. · Mülheim an der Ruhr

  • Robert Thimme, Prof.Dr. · Freiburg im Breisgau

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-09
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • Germany

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04510740 on ClinicalTrials.gov